[Cerebral vasospasm following subarachnoid hemorrhage. New aspects of diagnosis and therapy].
A comprehensive survey of the subject is given. Focal points are the discussions of calcium antagonists, pathophysiology of vasospasm and CBF-monitoring. Moreover, a novel neuromonitor is presented permitting bed-side work. In spite of the still unclarified etiology of vasospasm and the site of action of the calcium antagonists their early application is indicated for the prevention of cerebral vasospasm after subarachnoid haemorrhage.
Voth
D
D
Neurochirurgischen Universitätsklinik, Mainz.
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis* / Q000188:drug therapy; D013345:Subarachnoid Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D002121:Calcium Channel Blockers
Der zerebrale Vasospasmus nach Subarachnoidalblutung. Neue Aspekte der Diagnostik und Therapie.